CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
3.390
-0.150 (-4.24%)
At close: Sep 11, 2026, 4:00 PM EDT
3.420
+0.030 (0.88%)
After-hours: Sep 11, 2026, 4:58 PM EDT
CollPlant Biotechnologies Revenue
CollPlant Biotechnologies had revenue of $73.00K in the quarter ending March 31, 2026, a decrease of -96.45%. This brings the company's revenue in the last twelve months to $389.00K, down -84.26% year-over-year. In the year 2025, CollPlant Biotechnologies had annual revenue of $2.37M with 360.39% growth.
Revenue (ttm)
$389.00K
Revenue Growth
-84.26%
P/S Ratio
17.69
Revenue / Employee
$9,974
Employees
39
Market Cap
6.41M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.37M | 1.86M | 360.39% |
| Dec 31, 2024 | 515.00K | -10.44M | -95.30% |
| Dec 31, 2023 | 10.96M | 10.66M | 3,565.22% |
| Dec 31, 2022 | 299.00K | -15.34M | -98.09% |
| Dec 31, 2021 | 15.64M | 9.50M | 154.86% |
| Dec 31, 2020 | 6.14M | 3.82M | 164.75% |
| Dec 31, 2019 | 2.32M | -2.70M | -53.77% |
| Dec 31, 2018 | 5.01M | 4.55M | 982.94% |
| Dec 31, 2017 | 463.00K | 387.12K | 510.15% |
| Dec 31, 2016 | 75.88K | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bolt Biotherapeutics | 4.70M |
| Evogene | 1.66M |
| AIM ImmunoTech | 95.00K |
| Cardio Diagnostics Holdings | 14.45K |
| Creative Medical Technology Holdings | 3.00K |
| Ernexa Therapeutics | 1.00K |
CLGN News
- 1 day ago - CollPlant to Host LightSolver Investor Webinar on September 17, 2026 - PRNewsWire
- 7 days ago - CollPlant appoints Shlmoni to Board of Directors - TheFly
- 7 days ago - COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION - PRNewsWire
- 7 days ago - CollPlant Biotechnologies trading halted, news pending - TheFly
- 8 days ago - CollPlant completes acquisition of LightSolver - TheFly
- 8 days ago - COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR - PRNewsWire
- 10 days ago - CollPlant approves reverse share split - TheFly
- 10 days ago - COLLPLANT ANNOUNCES REVERSE SHARE SPLIT - PRNewsWire